AzTrials
AzTrials

Complication of Surgical ProcedureNCT05761821

Key Factors of Leadless Pacemaker Implantation With Implantation Site, Complications and Prognosis

An observational study of Complication of Surgical Procedure and Pacemaker Complication, run by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To investigate the relationship between key variables in leadless pacemaker implantation with implantation site, intraoperative complications and prognosis. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Leadless pacemaker
Type of treatment
Medical device
How many people
300 participants
Where
1 siteChina
Study dates
1 Oct 2022to 31 Dec 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients received implantation of leadless pacemaker

Who may be able to join

  • Patient received implantation of leadless pacemaker
  • Patient agreed to join into this study and signed informed consent

Who cannot join

  • Age < 18 years
  • Ventricular septal defect
  • History of mechanical tricuspid valve replacement
  • History of inferior vena cava filter placement
  • Pregnant or plan to be pregnant within 2 years
  • Life expectancy < 1 year
  • Patient was included in other studies that could introduce bias into this study

Trial locations and contacts

1 site in 1 country.

China1 site, 1 recruiting
  • Sun Yat-sen Memorial Hospital of Sun Yat-sen University

    Guangzhou, Guangdong, 510000

    Yangxin Chen, PhD, +8602081332360, chenyx39@mail.sysu.edu.cn

    Qi Guo, MD

    Recruiting

Other trials in China

About this study

Official title: Relationship Between Key Factors of Leadless Pacemaker Implantation With Implantation Site, Intraoperative Complications and Prognosis

To investigate the relationship between key variables in leadless pacemaker implantation with implantation site, intraoperative complications and prognosis.

Read the detailed description

In this study, we aim to include patients implated with leadless pacemakers, collect key variables and other clinical data during implantation of leadless pacemakers, and observe the final implantation site, intraoperative complications and prognosis information of patients. This study aims to clarify the relationship between key variables in leadless pacemaker implantation with implantation site, intraoperative complications and prognosis, and provide data support for the standardization of leadless pacemaker implantation process in China.

Being tested
Leadless pacemaker
Keywords
leadless pacemaker, complication, Prognosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Leadless pacemakerDevice

    All enrolled patients were implanted with leadless pacemaker.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Serious adverse events

    including dislodgement (including detachment), cardiac perforation, pericardial effusion, and serious infection

    Measured: Day 0 (Time of implantation)-Day 7

Secondary outcomes (4)
  1. Device-related complications

    Femoral venipuncture site hematoma, hemorrhage, pseudoaneurysm, arteriovenous fistula, tricuspid valve injury

    Measured: Day 0 (Time of implantation)-Day 7

  2. Device-related complications

    Femoral venipuncture site hematoma, hemorrhage, pseudoaneurysm, arteriovenous

    Measured: Day 0 (Time of implantation)-Year 2

  3. Serious adverse events

    including dislodgement (including detachment), cardiac perforation, pericardial effusion, and serious infection

    Measured: Day 0 (Time of implantation)-Year 2

  4. Re-intervention of devices

    extraction, re-implantation, or implantation of traditional transvenous pacemaker

    Measured: Day 0 (Time of implantation)-Year 2

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Mar 2023
  2. Study start1 Oct 2022
  3. Primary completion31 Dec 2024 (estimated)
  4. Study completion31 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05761821
Sponsor's protocol ID
SYSKY-2023-056-01
Status last verified
Feb 2023
First submitted
27 Feb 2023
Last updated
9 Mar 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Complication of Surgical Procedure and Pacemaker Complication, run by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Yangxin Chen, PhD (+8602081332360, chenyx39@mail.sysu.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Serious adverse events (time frame: Day 0 (Time of implantation)-Day 7). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in